Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
  1. Home
  2. ETF
  3. OCUL
OCUL logo

OCUL

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewTechnicalNews
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

OCUL News

Acuta Capital Reduces Stake in Ocular Therapeutix Significantly

4d agoFool

Acuta Capital Partners Reduces Ocular Therapeutix Holdings

4d agoNASDAQ.COM

Saturn V Capital Management Fully Exits Ocular Therapeutix

May 19 2026Fool

Saturn V Fully Exits Ocular Therapeutix Stake

May 19 2026NASDAQ.COM

Ocular Therapeutix Q1 2026 Earnings Call Insights

May 05 2026seekingalpha

Ocular Therapeutix to Announce Q1 Earnings on May 5th

May 04 2026seekingalpha

Ocular Therapeutix to Participate in Multiple Conferences

Apr 27 2026Newsfilter

AXPAXLI Demonstrates Unmatched Durability in Wet AMD Treatment

Apr 13 2026Newsfilter

Ocular Therapeutix Shares Surge 10.45% Ahead of Key Conferences

Apr 10 2026Yahoo Finance

Ocular Therapeutix to Participate in Multiple Scientific Conferences

Apr 01 2026Newsfilter

EyePoint Sues Ocular for False Claims on Duravyu

Mar 21 2026seekingalpha

VR Adviser, LLC Reduces Stake in Ocular Therapeutix

Mar 18 2026Fool

VR Adviser, LLC Sells Shares of Ocular Therapeutix

Mar 18 2026NASDAQ.COM

Wall Street Analysts Adjust GE Stock Ratings

Mar 03 2026Benzinga

OCUL Stock 52-Week High and Low Analysis

Mar 02 2026NASDAQ.COM

Ocular Therapeutix Shares Drop Amid Inflation Concerns

Feb 28 2026Yahoo Finance